April 22, 2024

5-Day Course: Gene Therapy Innovations – from science and manufacturing to patient benefit

5-Day Course: Gene Therapy Innovations – from science and manufacturing to patient benefit

EATRIS is hosting a 5-day course “Gene Therapy Innovations” from bench to patient in Belgium from 18-22 November together with the GET-IN project. PhD students and early PostDocs will learn from real-life scenarios presented by experts and group assignments. The course will address key aspects for successfully translating research into patient benefit like Manufacturing, Regulatory, Clinical aspects, Commercialisation and Reimbursement. Please help us to reach out to the excellent potential participants in your network (see announcement text to share via email below).

There is a 100€ discount for EATRIS members and an additional discount for participants from EU-13 countries.

For additional information or any feedback, please reach out to the training team (training@eatris.eu)

GENE THERAPY INNOVATIONS – FROM SCIENCE AND MANUFACTURING TO PATIENT BENEFIT

Date & Time 18-22 November 2024
Address KU Leuven 01.10 – Nicolas de le Villezaal – Celestijnenklooster – CBA (331-80) Willem de Croylaan 6 , 3001 Heverlee
Sciencepark Arenberg, Bio-Incubator Leuven NV, Gaston Geenslaan 3, 3001 Heverlee
UCB Pharma, Avenue de l’Industrie B – 1420 Braine-l’Alleud
Location Leuven, Belgium

JOIN US FOR THIS 5-DAY COURSE ON “GENE THERAPY INNOVATIONS” ON 18-22 NOVEMBER 2024 IN LEUVEN, BELGIUM.

The agenda of the course will address the 4 key challenges and bottlenecks of the gene therapy development cycle: Scientific, Manufacturing, Regulatory, and Reimbursement/Commercialisation. In addition, clinical aspects will be discussed.

The course is developed and proposed within the scope of the GET-IN doctoral network tackling critical gene therapy technology & knowledge gaps. It will be building on the knowledge of the online course and face-to-face curriculum on ATMPs (Cell and Gene Therapies) development that was developed within the ADVANCE project (2020-2023).

The core target group are the “next generation of gene therapy developers” – i.e. early-career biomedical academics (PhDs, Postdocs), including doctors in training, clinician-scientists and SME-based professionals, who are considered to be an important component of the labour market and the critical intermediaries of the gene therapy development pipeline.

Participants will:

  • Take a preparatory online course
  • hear keynote lectures by experts,
  • complete hands-on group assignments,
  • get a chance to present their research projects to peers,
  • go on tours of gene therapies production facilities (Leuven BioIncubator, UCB)
  • have plenty of time to network with peers!

Lecturers: Andrea Buzzi (European Medicines Agency), Rik Gijsberg (KU Leuven), David Morrow (EATRIS), Jan Schrooten (Antleron), Laetitia Malphettes (UCB), Liesbeth De Waele (UZ Leuven), Isabelle Huys (KU Leuven), …

TIME AND LOCATION

Start: 9.00 on 18 November

End: 12.00 on 22 November

 

APPLICATION

30 seats are available, first come first serve, and we recommend to register early!

Registration fee includes daytime catering (lunch and refreshments) plus 1 evening social activity.  Travel and accommodation are not included.

  • For GET-IN DCs, GET-IN members and EATRIS members: 550€
  • For participants from academia: 650€
  • For participants from industry: 850€
  • 2 seats at 350€ are reserved for participants from EU-13 countries: Bulgaria (BG), Croatia (HR), Cyprus (CY), Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Lithuania (LT), Malta (MT), Poland (PL), Romania (RO), Slovakia (SK) and Slovenia (SI)

Registration Link

register now

Our latest News

discover more
TSG Hoffenheim and Heidelberg University Hospital cooperate

TSG Hoffenheim and Heidelberg University Hospital cooperate

TSG Hoffenheim and Heidelberg University Hospital (UKHD) are entering into a partnership to focus more on the topic of mental health. The aim of the cooperation is to bring the Clinic for Child and Adolescent Psychiatry, the Clinic for General Psychiatry and the Sports Psychology Department of TSG closer together. More Information in German below. […]

Award-winning research in emergency medicine in Heidelberg

Award-winning research in emergency medicine in Heidelberg

Research is constantly being conducted at Heidelberg University Hospital to continuously improve patient care and patient safety. The emergency medicine department has already received several awards for its innovations and improvements. The Emergency Medicine Section of the Department of Anesthesiology at Heidelberg University Hospital (UKHD) recently received the Rudolf Frey Prize 2024 from the German […]

Psychotherapy via video in the GP practice helps with depression and anxiety

Psychotherapy via video in the GP practice helps with depression and anxiety

A new digital therapy concept provides people suffering from mental disorders with low-threshold and effective access to specialized psychosocial care. This can usefully complement existing services – as demonstrated by the PROVIDE-C study conducted by the Medical Faculty of Heidelberg University. The study was funded by the Federal Ministry of Education and Research (BMBF). Its […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp